已收盤 05-08 16:00:00 美东时间
-0.800
-3.81%
今日重点评级关注:Piper Sandler:维持Aclaris Therapeutics"超配"评级,目标价从7美元升至11美元;Evercore ISI集团:维持BioMarin Pharmaceutical"跑赢大市"评级,目标价从110美元升至120美元
05-06 11:29
Baldwin Insurance (NASDAQ:BWIN) is looking for Q2 Adj EPS of $0.44-$0.48 vs $0.64 analyst estimate. sees sales of $485.000 million-$495.000 million vs $524.275 million analyst estimate.
05-05 20:49
<span style="color:#999999;">编者按:聚焦公司高管观点与展望,深挖业绩背后的信息,助力投资者把握先机。</span><blockquote><p><span style="color:#fa1432;"><strong>业绩回顾</strong></span></p></blockquote><p>• 根据Baldwin保险集团Q1 2026业绩会实录,以下是财务业绩回顾摘要: ## 1. 财务业绩 **营收表现:** - 总营收5.322亿美元,有机营收增长2% - 分部门有机增长:保险咨询解决方案(IAS)增长4%,承保、产能与技术解决方案(UCTS)增长3%,主街保险解决方案(MIS)下降5% - 调整后有机营收增长为5%(剔除QBE建筑商账簿转移、医疗保险市场干扰和IAS收入确认程序变更影响) **盈利能力:** - 调整后EBITDA为1.372亿美元,同比增长21%(2025年Q1为1.138亿美元) - 调整后EBITDA利润率为25
05-05 12:12
华盛资讯5月5日讯,Baldwin Insurance Group, Inc. Class A公布2026财年Q1业绩,公司Q1营收5.32亿美元,同比增长28.7%,归母净利润0.02亿美元,同比下滑83.2%。
05-05 05:31
Baldwin Insurance stock falls ahead of earnings, with rising short interest, weak trend, and new AI expansion in focus.
05-05 01:54
This is a significant acceleration of the company's AI-driven transformation and a strengthening of its commitment to delivering differentiated client and colleague experiences at scale.Baldwin will integrate Claude
05-04 21:17
Companies Reporting Before The Bell • Pulse Biosciences (NASDAQ:PLSE) is likely...
05-04 19:11
今日重点评级关注:Ascendiant Capital:维持Banzai International"买入"评级,目标价从23美元升至24美元;Ascendiant Capital:维持Synergy CHC Corp."买入"评级,目标价从5美元升至5.5美元
04-15 11:31
B of A Securities analyst Joshua Shanker maintains Baldwin Insurance (NASDAQ:BWIN) with a Buy and lowers the price target from $38 to $36.
04-15 01:51
今日重点评级关注:Ascendiant Capital:维持RenovoRx"买入"评级,目标价从13美元升至13.5美元;Ascendiant Capital:维持Lucid Diagnostics"买入"评级,目标价从8.25美元升至9美元
04-10 18:27